Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple -Dose Safety, Pharmacokinetics, and Drug I-261025119
University of Arizona, Tucson, AZ, United States
Search grants from University of Arizona
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The role of TLR3 signaling in Chlamydia caused urogenital pathology
PS09-902 Comprehensive Std Prevention Systems (CSPS)
Development of a Pan-Oncogenic HPV Preventive Vaccine
Pediatric Hematology/Oncology
Residency Training in Gim and/OR Gp
Recently added grants:
TMS-EEG investigation of prefrontal cortical excitability in depression and rTMS treatment response
Medicaid Value Based Payment Models and Healthcare Equity for Adults with Serious Mental Illnesses
Basal Ganglia Cortical Coupling and Connectivity Changes in PD and DBS
Neural Basis of Behavioral Arousal
Synaptic Function within Mature Central Pain Networks after Neonatal Injury
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025119-002
Application #
6828863
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85722
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple -Dose Safety, Pharmacokinetics, and Drug I-261025119
/ University of Arizona
NIH 2002
N01 CA
Phase I Single and Multiple -Dose Safety, Pharmacokinetics, and Drug I-261025119
/ University of Arizona
Comments
Be the first to comment on this grant